Skip to main content
AREAZINENotices · US CA UK AU

MHRA17 Aug 2026

National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)

The Medicines and Healthcare products Regulatory Agency published a recall notice for National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA) on 17 Aug 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.

Recall

The recall notice

Issued by
Medicines and Healthcare products Regulatory Agency
Issued
09:30, 17 Aug 2026
Alert class
Patient Safety Alert
Official source
Medicines and Healthcare products Regulatory Agency: the notice at its source

The latest from the MHRAEvery warning and recall in the United Kingdom

Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.

The notice as issued

ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected interr…

Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.

The record around this notice